Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H15NO2 |
Molecular Weight | 157.2102 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC[C@H]1CC[C@@H](CC1)C(O)=O
InChI
InChIKey=GYDJEQRTZSCIOI-LJGSYFOKSA-N
InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7-
Molecular Formula | C8H15NO2 |
Molecular Weight | 157.2102 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:56:25 UTC 2023
by
admin
on
Sat Dec 16 16:56:25 UTC 2023
|
Record UNII |
6T84R30KC1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
988
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
WHO-ATC |
B02AA02
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
WHO-VATC |
QB02AA02
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
NDF-RT |
N0000175632
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
NDF-RT |
N0000175634
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
10.2
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
NDF-RT |
N0000175632
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
8885
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
||
|
NCI_THESAURUS |
C78311
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2713
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
C47765
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
10691
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB11214MIG
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
6573
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
CHEMBL877
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
m11000
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | Merck Index | ||
|
Tranexamic Acid
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
TRANEXAMIC ACID
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
214-818-2
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
291305
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
DTXSID3045350
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
DB00302
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
1672745
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
6T84R30KC1
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
D014148
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
1197-18-8
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
2060
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
48669
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
6T84R30KC1
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY | |||
|
100000091040
Created by
admin on Sat Dec 16 16:56:26 UTC 2023 , Edited by admin on Sat Dec 16 16:56:26 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
TARGET -> INHIBITOR |
Inhibits fibrinolysis by blocking the binding site of lysine on plasminogen.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
One percent percent of an oral dose are excreted as a dicarboxylic acid
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |